Plain-English translation of NCT05147597 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is checking whether a specific questionnaire about breathing and quality of life—originally created for idiopathic pulmonary fibrosis patients—works well when used in Turkish. Researchers need to make sure the questionnaire is translated correctly and measures what it's supposed to measure in Turkish-speaking patients.
Good medical tools need to work equally well in all languages and cultures. This questionnaire helps doctors understand how lung disease affects patients' daily lives, but it hasn't been properly tested in Turkish yet. This study fills that gap.
You will fill out three questionnaires: one about your background, one general breathing questionnaire, and one specifically designed for lung fibrosis patients. You'll complete the same questionnaires again one week later so researchers can check if the answers are consistent. The entire process takes place over about two weeks, with no medication or invasive procedures involved.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
Turkey (Türkiye)
Enrollment target
~180 participants
Started
January 2022
Primary completion
May 2025
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2026.